ARCHIVES

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 18 | May 4, 2001

Download PDF Visit The Full Archive

Related Articles

Levine Leaves Presidency Of Rockefeller University.

February 15, 2002

Abraxane and Gemcitabine Improves Overall Survival

November 30, 2012

DCBD Board Okays Concept for Animal Holding Recompetition

December 5, 1986

Facilities Survey To Include All Institutions With $200,000 Or More in NCI Support

October 5, 1984

House Panel Targets AWP For Medicare Drug Pricing.

October 5, 2001

NCI advisors approve recompetition of $62 million phase II contracts program.

November 19, 2004